MiR-140-5p Overexpression Protects Against Lipopolysaccharide-Induced Necrotizing Pneumonia Targeting Toll-Like Receptor 4

Overview

Journal Cell Mol Bioeng

Publisher Springer

Specialty Biomedical Engineering

Date 2021 Jul 23

PMID 34295443

Citations 1

Authors

Haichao Wang

Changhao Wu

Dehui Kong

Affiliations

Soon will be listed here.

Abstract

Objective: This study is to identify the effects of miRNA-140-5p on necrotizing pneumonia (NP) and its underlying mechanism.

Methods: The mRNA levels of miRNA-140-5p and TLR4 and secretion of IL-1β, IL-6, and TNF-α in peripheral blood from children with NP and healthy volunteers were determined using qRT-PCR and specific ELISAs. The interactions between miRNA-140-5p and TLR4 were investigated using a dual-luciferase reporter system. Cell viabilities were determined using a CCK-8 assay. qRT-PCR, western blotting, and specific ELISAs were applied to determine the expressions of genes in the cells. Peripheral blood from children with NP had significantly elevated levels of TLR4 but significantly lower levels of miR-140-5p compared to the control.

Results: Spearman's rank correlation analysis showed a negative correlation between TLR4 and miR-140-5p. miR-140-5p regulated the expressions of TLR4 in A549 cells. Additionally, LPS induced a significant enhancement in the levels of TLR4 but significant reduction in the levels of miR-140-5p. The overexpression of miR-140-5p suppressed cell apoptosis and induced the release of inflammatory cytokines in the LPS-induced A549 cells.

Conclusion: The underlying mechanisms of miR-140-5p on the regulation of TLR4 are in part by the regulation of p65. The miR-140-5p inhibits necrotizing pneumonia by regulating TLR-4 via TNF-p65 signaling pathway.

Supplementary Information: The online version contains supplementary material available at 10.1007/s12195-021-00673-0.

Citing Articles

Novel Biomarker Panel of Let-7d-5p and MiR-140-5p Can Distinguish Latent Tuberculosis Infection from Active Tuberculosis Patients.

Liu J, Li Y, Liu T, Shi Y, Wang Y, Wu J Infect Drug Resist. 2023; 16:3847-3859.

PMID: 37346367 PMC: 10281287. DOI: 10.2147/IDR.S412116.

References

Rouzic N, Janvier F, Libert N, Javouhey E, Lina G, Nizou J . Prompt and successful toxin-targeting treatment of three patients with necrotizing pneumonia due to Staphylococcus aureus strains carrying the Panton-Valentine leukocidin genes. J Clin Microbiol. 2010; 48(5):1952-5. PMC: 2863892. DOI: 10.1128/JCM.01892-09. View

Li X, Wang J, Wu H, Guo P, Wang C, Wang Y . Reduced peripheral blood miR-140 may be a biomarker for acute lung injury by targeting Toll-like receptor 4 (TLR4). Exp Ther Med. 2018; 16(4):3632-3638. PMC: 6143831. DOI: 10.3892/etm.2018.6599. View

Yang H, Wang J, Fan J, Zhang Y, Zhao J, Dai X . Ilexgenin A exerts anti-inflammation and anti-angiogenesis effects through inhibition of STAT3 and PI3K pathways and exhibits synergistic effects with Sorafenib on hepatoma growth. Toxicol Appl Pharmacol. 2016; 315:90-101. DOI: 10.1016/j.taap.2016.12.008. View

Fei S, Cao L, Pan L . microRNA‑3941 targets IGF2 to control LPS‑induced acute pneumonia in A549 cells. Mol Med Rep. 2018; 17(3):4019-4026. DOI: 10.3892/mmr.2017.8369. View

Masters I, Isles A, Grimwood K . Necrotizing pneumonia: an emerging problem in children?. Pneumonia (Nathan). 2017; 9:11. PMC: 5525269. DOI: 10.1186/s41479-017-0035-0. View

Jiang K, Zhang T, Yin N, Ma X, Zhao G, Wu H . Geraniol alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis. Oncotarget. 2017; 8(41):71038-71053. PMC: 5642616. DOI: 10.18632/oncotarget.20298. View

Labandeira-Rey M, Couzon F, Boisset S, Brown E, Bes M, Benito Y . Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science. 2007; 315(5815):1130-3. DOI: 10.1126/science.1137165. View

Beutler B . Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol. 2000; 12(1):20-6. DOI: 10.1016/s0952-7915(99)00046-1. View

Miller S, Ernst R, Bader M . LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol. 2004; 3(1):36-46. DOI: 10.1038/nrmicro1068. View

10.

Kaisho T, Akira S . Toll-like receptors and their signaling mechanism in innate immunity. Acta Odontol Scand. 2001; 59(3):124-30. DOI: 10.1080/000163501750266701. View

11.

Standiford L, Standiford T, Newstead M, Zeng X, Ballinger M, Kovach M . TLR4-dependent GM-CSF protects against lung injury in Gram-negative bacterial pneumonia. Am J Physiol Lung Cell Mol Physiol. 2011; 302(5):L447-54. PMC: 3311511. DOI: 10.1152/ajplung.00415.2010. View

12.

Soifer H, Rossi J, Saetrom P . MicroRNAs in disease and potential therapeutic applications. Mol Ther. 2007; 15(12):2070-9. DOI: 10.1038/sj.mt.6300311. View

13.

Liu Y, Yin H, Zhao M, Lu Q . TLR2 and TLR4 in autoimmune diseases: a comprehensive review. Clin Rev Allergy Immunol. 2013; 47(2):136-47. DOI: 10.1007/s12016-013-8402-y. View

14.

Chuang C, Chen T, Cherng Y, Tai Y, Chen T, Chen R . Lipopolysaccharide induces apoptotic insults to human alveolar epithelial A549 cells through reactive oxygen species-mediated activation of an intrinsic mitochondrion-dependent pathway. Arch Toxicol. 2010; 85(3):209-18. DOI: 10.1007/s00204-010-0585-x. View

15.

McAlinden A, Im G . MicroRNAs in orthopaedic research: Disease associations, potential therapeutic applications, and perspectives. J Orthop Res. 2017; 36(1):33-51. PMC: 5840038. DOI: 10.1002/jor.23822. View

16.

Zhou W, Wang X, Yin D, Xue L, Ma Z, Wang Z . Effect of miR-140-5p on the regulation of proliferation and apoptosis in NSCLC and its underlying mechanism. Exp Ther Med. 2019; 18(2):1350-1356. PMC: 6614735. DOI: 10.3892/etm.2019.7701. View

17.

Guo H, Qi R, Sheng J, Liu C, Ma H, Wang H . MiR-155, a potential serum marker of extramammary Paget's disease. BMC Cancer. 2018; 18(1):1078. PMC: 6247506. DOI: 10.1186/s12885-018-4994-1. View

18.

Kumar H, Kawai T, Akira S . Toll-like receptors and innate immunity. Biochem Biophys Res Commun. 2009; 388(4):621-5. DOI: 10.1016/j.bbrc.2009.08.062. View

19.

Hacimustafaoglu M, Celebi S, Sarimehmet H, Gurpinar A, Ercan I . Necrotizing pneumonia in children. Acta Paediatr. 2004; 93(9):1172-7. DOI: 10.1080/08035250410026699. View

20.

Kayagaki N, Wong M, Stowe I, Ramani S, Gonzalez L, Akashi-Takamura S . Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science. 2013; 341(6151):1246-9. DOI: 10.1126/science.1240248. View